Brain activity in youth may presage Alzheimer's pathology
Main Category: Alzheimer's / DementiaArticle Date: 26 Aug 2005 - 3:00 PDT
Researchers who used five different medical imaging techniques to study the brain activity of 764 people, including those with Alzheimer's disease, those on the brink of dementia, and healthy individuals, have found that the areas of the brain that young, healthy people use when daydreaming are the same areas that fail in people who have Alzheimer's disease.
On the basis of their data, the researchers are proposing a new hypothesis that suggests that Alzheimer's disease may be due to abnormalities in the regions of the brain that operate the "default state." This is the term used to describe the cognitive state people defer to when musing, daydreaming, or thinking to themselves.
Writing in the August 24, 2005, issue of the Journal of Neuroscience, the researchers state that "the default activity patterns of the brain may, over many years, augment a metabolic- or activity-dependent cascade that participates in Alzheimer's disease pathology."
"The regions of the brain we tend to use in our default state when we are young are very similar to the regions where plaques form in older people with Alzheimer's disease," said the lead author of the study, Randy L. Buckner, a Howard Hughes Medical Institute (HHMI) investigator at Washington University in St. Louis. "This is quite a remarkable convergence that we did not expect," Buckner adds.
The new findings are important because they could help scientists and clinicians identify and understand the beginnings of what is probably a cascade of events that ultimately leads to Alzheimer's.
The most common form of dementia among older people, Alzheimer's is characterized outwardly by the erosion of language, thought and memory. Within the brains of people with Alzheimer's disease, abnormal clumps of plaque and tangled bundles of fibers form and characterize the physical manifestation of the disease, which may affect as many as 4.5 million Americans. The causes of the disease are unknown.
The availability of powerful imaging techniques and the ability to merge different sets of imaging data through new bioinformatics and statistical methods enabled Buckner and his team to construct a picture of Alzheimer's from molecular changes to the structural and functional manifestations of the disease. In the process, the team unexpectedly observed that the regions of the brain that light up when we slip into comfortable patterns of thought are the same as those that, later in life, exhibit the disabling clumps of plaque characteristic of Alzheimer's, a disease that most frequently manifests itself after age 60.
That remarkable correlation, said Buckner, suggests that dementia may be a consequence of the everyday function of the brain.
"It may be the normal cognitive function of the brain that leads to Alzheimer's later in life," said Buckner. "This was not a relationship that we had even considered. The hypothesis is that the cascade of events that leads to Alzheimer's begins at young adulthood."
The default state, according to Buckner, is characterized by metabolic activity in specific regions of the brain, notably the posterior and cortical regions. "These regions were active in the default states in young adults and also showed amyloid (plaque) deposition in older adults with Alzheimer's disease," the researchers write in the new Journal of Neuroscience paper.
"The key insight is that brain activity and metabolism are not uniform across the brain," Buckner said. "When we looked at people on the cusp of dementia, we saw a loss of brain tissue in the regions we predicted it would occur," based on our observations of metabolism.
Insight from the new study may help explain why the memory systems of the human brain are vulnerable. "We appear to use memory systems often in our default states. This may help us to plan and solve problems. Maybe it helps us be creative. But it may also have metabolic consequences," Buckner explained.
The newfound correlation may also have future clinical implications as Alzheimer's is typically diagnosed when it is too late to intervene. To develop and administer effective treatments, clinicians will need to figure out ways to detect the disease in its earliest stages, said William Klunk, associate professor of psychiatry at the University of Pittsburgh and a co-author of the Journal of Neuroscience paper.
"You have to get to this pathology before it has its biggest effect, before it has done its damage," said Klunk, who has developed techniques for imaging the amyloid plaques in Alzheimer's patients.
The findings reported in the new study, he said, suggest that there is now the potential to begin to trace the patterns of the disease and develop methods to detect it before the clinical symptoms set in.
Buckner emphasized that the notion of a causative relationship between everyday metabolic functions of the brain and Alzheimer's remains a hypothesis. However, new studies may help "show if amyloid (plaque) deposition is really dependent on metabolism. Can we find a biologically plausible reason for how metabolism causes Alzheimer's disease?"
Moreover, looking to see if the phenomenon varies or is the same among many individuals will be required to firm up the link between brain metabolism in early life and Alzheimer's pathology later in life. Understanding variation may also help us to explain why some people are at high risk for Alzheimer's disease.
"We are very interested in exploring these new observations to understand who is at risk and who is protected from Alzheimer's," said Buckner.
In addition to Buckner and Klunk, authors of the Journal of Neuroscience article include Abraham Z. Snyder, Benjamin J. Shannon, Gina LaRossa, Rimmon Sachs, Anthony F. Fotenos, Yvette I. Sheline, John C. Morris and Mark A. Mintun, all of Washington University; and Chester Mathis of the University of Pittsburgh.
Jim Keeley
keeleyj@hhmi.org
301-215-8858
Howard Hughes Medical Institute
http://www.hhmi.org
Visit our alzheimer's / dementia section for the latest news on this subject.
MLA
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/29676.php>
APA
http://www.medicalnewstoday.com/releases/29676.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Visitor Opinions In Chronological Order (1)
Both due to low DHEA
posted by James Michael Howard on 26 Aug 2005 at 1:00 pmIt is my hypothesis (1985) that low DHEA may result in Alzheimer's disease (AD). DHEA naturally declines in old age and DHEA is lower in AD. This decline in DHEA has been connected with "decreased beta-amyloid precursor protein and a consecutive increase in beta-amyloid deposition" (Ann N Y Acad Sci. 1995 Dec 29;774:300-3). In fact, treating oligodendrocytes with beta-amyloid increased DHEA formation (J Neurochem. 2000 Feb;74(2):847-59). This response mechanism is reduced in AD. Low DHEA may account for similarities in AD and the "young adult default state."
I suggest DHEA stimulates all tissues, especially brain tissues. Therefore, activation of the regions involved in the default state may represent a switch of use of DHEA to these structures when DHEA is not being used by anterior tissues. This switch in activity to one set of structures during decreased activity of another set of structures has been demonstrated in another "default state" area (Neuroimage. 2004 Mar;21(3):1167-73). That is, these tissues may only be activated when DHEA increases when other tissues reduce their use of DHEA, so they may be vulnerable to deactivation by low DHEA and should be affected early. The posterior cingulate cortex is adversely affected very early in AD (Ann Neurol. 1997 Jul;42(1):85-94). In young adults these "default" areas are activated more than older adults because of increased DHEA of youth. Their connection with AD is the fact that they are more vulnerable to the loss of DHEA of old age.
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.






